C21 Investments Inc.
Disclosed SEC business address
SUITE 1900-855 WEST GEORGIA STREET, VANCOUVER, V6C 3H4
C21 Investments Inc. (ticker CWLXF, CIK 0000831609) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Medicinal Chemicals & Botanical Products (SIC 2833). Every item is grounded on the cited public source — no figures are fabricated.
Full evidence detail
Company deep views this month: 3 of 5.
Filing intelligence
105 filings ingested; deep FILING ANALYSIS shown for 6 filings.
- FACT Only one ingested version of this accession exists; no intra-document revisions have been observed. Change tracking for this filing requires ≥2 ingested versions. 2026-08-21 source ↗
- ANALYSIS This 6-K was filed 11 days after the previous ingested 6-K (2026-08-10). 85 filings of this type are ingested. 2026-08-21 source ↗
- UNKNOWN Changed risk-factor language (Item 1A): not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
- UNKNOWN MD&A highlights: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
- UNKNOWN Material business developments: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
- UNKNOWN Debt / capital-structure changes: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
- UNKNOWN Acquisitions / divestitures: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
- UNKNOWN Litigation / regulatory matters: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
Latest developments
Most recent SEC filing events ingested for this company (newest first).
- FACT 6-K filed (period 2026-06-30) 2026-08-21 source ↗
- FACT 6-K filed (period 2026-08-07) 2026-08-10 source ↗
- FACT 6-K filed (period 2026-08-07) 2026-07-09 source ↗
- FACT 6-K filed (period 2026-06-19) 2026-06-22 source ↗
- FACT 6-K filed (period 2026-06-15) 2026-06-15 source ↗
- FACT 20-F filed (period 2026-03-31) 2026-06-12 source ↗
- FACT 6-K filed (period 2026-03-31) 2026-06-12 source ↗
- FACT S-8 filed 2026-03-19 source ↗
- FACT 6-K filed (period 2026-02-10) 2026-02-10 source ↗
- FACT 6-K filed (period 2025-12-31) 2026-02-10 source ↗
Insider ownership filings
No insider ownership filings (Forms 3/4/5) have been ingested for this company. This is not a claim that none exist.
- UNKNOWN No insider ownership filings (Forms 3/4/5) have been ingested for this company. This is not a claim that none exist.
Geographic footprint (disclosed)
Geographic footprint limited to locations disclosed in ingested evidence.
- FACT Principal executive office (disclosed): VANCOUVER, V6C 3H4
- FACT Mailing address (disclosed): VANCOUVER, V6C 3H4
- FACT State/country of incorporation (disclosed): British Columbia, Canada
Industry classification (disclosed)
Industry classification as disclosed by the issuer's SEC record.
- FACT Primary industry (disclosed SIC): Medicinal Chemicals & Botanical Products (SIC 2833)
- FACT SEC filer category: Non-accelerated filer<br>Emerging growth company
Supply chain
No supplier or customer relationships are disclosed in ingested evidence. Supply-chain relationships are shown only when explicitly disclosed and cited; undisclosed relationships are never inferred.
- UNKNOWN No supplier or customer relationships are disclosed in ingested evidence. Supply-chain relationships are shown only when explicitly disclosed and cited; undisclosed relationships are never inferred.
Risk factors
Risk-factor language requires ingested filing document bodies.
- UNKNOWN Risk-factor language requires ingested filing document bodies.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-24T18:50:01.003939+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:36:04.774189+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:36:08.792828+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:36:01.218324+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.